Patent · US Active

Biocatalysts for ezetimibe synthesis

US10544400B2 · kind B2 · utility

1Cited by
36References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2018
Grant dateJan 28, 2020
Priority date—
Expiry dateJul 11, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P17/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.